IFX+ MTX | Triple | MTX | p | |
---|---|---|---|---|
Age (yrs) | 10.5 (4.5—14.9) | 8.2 (4.8—13.3) | 10.1 (4.0—14.4) | 0.06 |
Female (%) | 14 (70) | 14 (70) | 11 (55) | 0.21 |
Time (months) from disease onset | 0.82 (0.0-2.7) | 1.77 (0.03—7.0) | 1.18 (0.03—7.1) | 0.20 |
Rheumatoid factor positive | 0 | 1 (5) | 0 | |
JIA subtype | ||||
Polyarthritis, seronegative | 19 (95) | 16 (80) | 15 (75) | |
Enthesitis-related arthritis (%) | 1 (5) | 3 (15) | 4 (20) | |
Polyarthritis, seropositive | 0 | 1 (5) | 0 | |
Psoriatic arthritis | 0 | 0 | 1 (5) | |
CHAQ | 0.49 (0—1.75) | 0.71 (0—2.00) | 1.07 (0—1.88) | 0.01 |
JADAS10 | 17.1 (6.9—23.4) | 20.1 (9.8—29.8) | 21.9 (11.4—30.6) | 0.01 |
Pain-VAS | 24.5 (0—90) | 37.6 (4—78) | 46.7 (2—85) | 0.02 |
PhS | 28.2 (21.4—35.1) | 28.8 (17.9—39.6) | 21.9 (12.8—30.9) | 0.46 |
PsS | 51.4 (27.1—58.5) | 48.9 (37.1—62.8) | 52.8 (40.2—65.8) | 0.28 |